PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
November 1, 2025The Journal of ImmunologyOpen Access

Anti-CD3 mAb treatment reshapes CD8+ T cells in the islets in autoimmune diabetes 4144

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYing WuMSMaxwell SpurrellSDSongyan Deng

Discussion

Loading...

Member takes

Overview

Single-cell analysis shows anti-CD3 treatment alters CD8+ T cells and beta cell states in type 1 diabetes, suggesting mechanisms of long-term tolerance.

Key Points

  • This research aims to characterize the impact of anti-CD3 mAb treatment on CD8+ T cells and beta cells in autoimmune diabetes.
  • Characterized single-cell transcriptome of islets from remitter NOD mice post anti-CD3 treatment.
  • Compared CD8+ T cells from remitted NOD mice to prediabetic controls.
  • Analyzed expression of specific genes in autoreactive CD8+ T cells and beta cells.
  • CD8+ T cells in remitted NOD mice exhibit a more diverse repertoire.
  • CD8+ T cells showed a naïve-like differentiation trajectory relative to controls.
  • Islet beta cells underwent remodeling towards a more differentiated state.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/69254f89c0ce034ddc359774https://doi.org/10.1093/jimmun/vkaf283.1862
View Full Paper
Ask AI
Bookmark
Share